Part-Time
Posted on 9/24/2025
Global healthcare product distributor and services
No salary listed
Wyomissing, PA, USA
In Person
Henry Schein is a global supplier of healthcare products and services. It operates in two segments: healthcare distribution, which provides dental and medical consumables, equipment, and laboratory products to dentists, physicians, and veterinarians; and technology and value-added services, which offers practice management software, e-commerce solutions, and financial services. The company works by supplying healthcare professionals with a broad range of products and by offering software, online tools, and financing options to run their practices more efficiently. Compared with competitors, Henry Schein combines a wide product catalog with software and financial services, creating a one-stop platform for practice needs across more than 30 countries, with a strong focus on North America. Its goal is to be a trusted partner for healthcare professionals by supporting their day-to-day operations and growth through integrated distribution, technology, and financing solutions.
Company Size
10,001+
Company Stage
IPO
Headquarters
Town of Huntington, New York
Founded
1932
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Paid Vacation
Paid Parental Leave
Short Term Disability
Health Savings Account/Flexible Spending Account
Education Benefits
Henry Schein has announced its board will shrink from 15 to 10 members following its 2026 annual meeting, with longtime director and former chairman Stanley Bergman retiring after 44 years alongside four other directors not standing for re-election. The board reshaping coincides with Frederick Lowery's appointment as chief executive, effective March 2026, framing the changes as part of a broader leadership transition. This governance shift adds uncertainty to Henry Schein's ongoing transformation, which includes a push towards higher-margin software and specialty products alongside cost-saving initiatives driven by KKR. Analysts project $14.8 billion revenue and $595.4 million earnings by 2029. The company's narrative suggests continued focus on digital offerings, specialty products and international expansion under new leadership.
Stanley Bergman, who fled apartheid South Africa at 26, stepped down this month as CEO of Henry Schein after 36 years leading the company. He transformed the regional dental supplier from $225 million in revenue to a $13.2 billion Fortune 500 medical and dental distributor. Bergman joined as CFO in 1980, attracted by the founders' commitment to aligning business with social values. Under his leadership, Henry Schein appeared on Fortune's World's Most Admired Companies list for 21 consecutive years. His leadership philosophy emphasised hiring for character over credentials, diversifying perspectives, expanding through joint ventures, and serving society alongside stakeholders. The company's "Give Kids a Smile" initiative provides free dental screenings to over 300,000 children annually. Fred Lowery succeeded Bergman as CEO on 2 March, with Bergman remaining chairman.
Henry Schein, a $9 billion global healthcare supplier, has opened its first integrated training facility in Southlake, Texas. The Dallas Discovery Center spans 8,300 square feet at 1080 S. Kimball Ave., featuring eight experience labs, two training rooms, a boardroom and an attached warehouse. The facility serves as both a training centre for sales associates and a showroom for potential clients. It includes fully equipped dental labs, an ambulatory surgery room, 3D printing stations, sterilisation equipment and a functioning laboratory with blood-drawing and diagnostic tools. Henry Schein, headquartered in Melville, New York, recorded $13.2 billion in sales across 34 countries in 2025. The company previously opened an 811,000-square-foot distribution centre in Alliance in 2024. New CEO Frederick Lowery attended the facility's opening on 2nd March.
Henry Schein, the world's largest provider of healthcare solutions to office-based dental and medical practitioners, will present at two investor conferences in March. The company will appear at Leerink's Global Healthcare Conference in Miami on 9 March at 10:00 EST and Barclays 28th Annual Global Healthcare Conference on 10 March at 10:30 EST. Both presentations will be available via live webcast on the company's website, with replays accessible afterwards. Henry Schein, a FORTUNE 500 company headquartered in Melville, New York, operates in 34 countries and serves over one million customers globally. The company reported sales of $13.2 billion in 2025.
Henry Schein's assessed fair value has risen to $83.21 from $78.14, aligning with multiple analyst upgrades that lifted price targets to the $87–$100 range. Several firms, including Baird, Evercore ISI and JPMorgan, raised targets following improved dental demand indicators and Q4 results. Baird cited three consecutive months of modest patient demand rebound and forecast double-digit earnings growth starting in 2027, lifting its target to $104. However, UBS, Mizuho and Leerink maintained cautious neutral ratings despite modest target increases to $87–$88. The company appointed Frederick Lowery as CEO effective 2 March 2026, whilst Stanley Bergman transitions to Chairman after 35 years. Henry Schein guided 2026 sales growth of 3–5% and repurchased 2.8 million shares for $200 million.